BNP Paribas Financial Markets’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $937K | Buy |
19,257
+842
| +5% | +$41K | ﹤0.01% | 2236 |
|
|
2025
Q1 | $627K | Sell |
18,415
-64,579
| -78% | -$2.2M | ﹤0.01% | 2273 |
|
|
2024
Q4 | $3.27M | Sell |
82,994
-4,962
| -6% | -$195K | ﹤0.01% | 1431 |
|
|
2024
Q3 | $4.13M | Sell |
87,956
-48,377
| -35% | -$2.27M | ﹤0.01% | 1091 |
|
|
2024
Q2 | $7.36M | Sell |
136,333
-12,609
| -8% | -$681K | 0.01% | 861 |
|
|
2024
Q1 | $10.2M | Buy |
148,942
+106,652
| +252% | +$7.27M | 0.01% | 771 |
|
|
2023
Q4 | $2.65M | Sell |
42,290
-87,212
| -67% | -$5.46M | ﹤0.01% | 1265 |
|
|
2023
Q3 | $5.88M | Buy |
129,502
+76,675
| +145% | +$3.48M | 0.01% | 813 |
|
|
2023
Q2 | $2.97M | Buy |
52,827
+5,150
| +11% | +$289K | ﹤0.01% | 1096 |
|
|
2023
Q1 | $2.16M | Sell |
47,677
-42,591
| -47% | -$1.93M | ﹤0.01% | 1301 |
|
|
2022
Q4 | $3.67M | Buy |
90,268
+29,143
| +48% | +$1.18M | 0.01% | 1018 |
|
|
2022
Q3 | $3.99M | Buy |
61,125
+55,656
| +1,018% | +$3.64M | 0.01% | 1045 |
|
|
2022
Q2 | $332K | Sell |
5,469
-16,424
| -75% | -$998K | ﹤0.01% | 2256 |
|
|
2022
Q1 | $1.37M | Sell |
21,893
-3,611
| -14% | -$227K | ﹤0.01% | 1617 |
|
|
2021
Q4 | $1.93M | Buy |
25,504
+24,331
| +2,074% | +$1.84M | ﹤0.01% | 1549 |
|
|
2021
Q3 | $131K | Buy |
1,173
+13
| +1% | +$1.46K | ﹤0.01% | 2593 |
|
|
2021
Q2 | $188K | Buy |
1,160
+569
| +96% | +$92.1K | ﹤0.01% | 2299 |
|
|
2021
Q1 | $72K | Sell |
591
-14,056
| -96% | -$1.71M | ﹤0.01% | 2930 |
|
|
2020
Q4 | $2.24M | Buy |
14,647
+7,514
| +105% | +$1.15M | ﹤0.01% | 1093 |
|
|
2020
Q3 | $597K | Buy |
7,133
+808
| +13% | +$67.6K | ﹤0.01% | 1554 |
|
|
2020
Q2 | $465K | Sell |
6,325
-32,029
| -84% | -$2.35M | ﹤0.01% | 1563 |
|
|
2020
Q1 | $1.63M | Buy |
38,354
+37,149
| +3,083% | +$1.58M | ﹤0.01% | 1171 |
|
|
2019
Q4 | $73.4K | Sell |
1,205
-23,577
| -95% | -$1.44M | ﹤0.01% | 2787 |
|
|
2019
Q3 | $1.02M | Buy |
24,782
+23,911
| +2,745% | +$980K | ﹤0.01% | 1302 |
|
|
2019
Q2 | $41K | Buy |
+871
| New | +$41K | ﹤0.01% | 2922 |
|